Opus advises AEA on its acquisition of Verdesian Life Sciences

Category: Deal Announcement

Opus Corporate Finance LLP advises AEA Investors LP (“AEA”) on its acquisition of Verdesian Life Sciences (“Verdesian”) which closed in February 2021.

Opus is delighted to have advised AEA on their successful acquisition of Verdesian, a leading US agrochemicals platform that develops patented biological, nutritional, fertilizer enhancers, seed treatment and inoculant technologies for high-value specialty crops, row crops, and turf and ornamental markets. Verdesian’s products promote sustainable agricultural practices by improving nutrient uptake and reducing the need for conventional chemicals.

This is a market leading transaction and an exciting step in the development of Opus’ Chemicals franchise.

For further information please contact: Chris Carlisle and Keegan Harris.